Your partner in science for end-to-end CRDMO solutions
Jubilant Biosys, a subsidiary of Jubilant Pharmova, is a leading contract research, development and manufacturing organization in India and provides innovative drug discovery services to the global pharmaceutical industry.
As a partner in drug discovery and development services, Jubilant Biosys offers unique and specialized support that covers the entire drug discovery process. If you are looking for quality solutions incorporated with the best practices in drug discovery domain, we are the right partner for you.
Our integrated drug discovery services span Target Validation (TV), Hit Identification (HI) to Lead Optimization (LO) & Pre-clinical Candidate (PCC) across multiple therapeutic areas. With well enabled capabilities in oncology, metabolic disorders, CNS, pain and inflammation Jubilant, as an integrated discovery service provide has rapidly emerged as a leading collaborator for biotechnology and pharmaceutical companies worldwide.
Jubilant’s expertise in discovery informatics, computational chemistry / molecular modelling, medicinal chemistry, structural biology, in-vitro pharmacology ,DMPK, in-vivo pharmacology and toxicology span over 20 years of successful delivery in first in class and best in class targets.
Jubilant operates on a customized approach developing innovative solutions that are relevant to target and add value to the program. To suit each client’s requirements in the best possible manner, our business models offer flexibility:
Jubilant collaborates with the world’s leading pharmaceutical and biotech companies, academic institutions and research foundations. we are committed to delivery and proven our capability by delivering outcome in shorter timelines. The hallmark of Jubilant’s collaborative model is the creation of value to partners.
